SKYRIZI 150 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA

Abbvie Deutschland Gmbh & Co. Kg🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 2af0f91545d0bd5b
Drug Cima Aemps Name: SKYRIZI 150 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA
Register Number: 1191361003
Holder Company Name: Abbvie Deutschland Gmbh & Co. Kg
Marketing Company Name: Abbvie Spain, S.L.U.
Holder Company Detail Path: /organization/abbvie-deutschland-gmbh-and-co-kg
Authorization Date: 2021-06-28
Dosage Form: SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA
Dose: 150 mg
Route Of Administration: VÍA SUBCUTÁNEA
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Abbvie Deutschland Gmbh & Co. Kg
Company Detail Path: /organization/abbvie-deutschland-gmbh-and-co-kg

RISANKIZUMAB

150 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 28, 2021

Approval ID

2af0f91545d0bd5b

Type

Standard